Bronchopulmonary dysplasia: Impact of surfactant replacement therapy

S. A. McColley*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

14 Scopus citations


Bronchopulmonary dysplasia is a major contributor to the morbidity and mortality of infants born prematurely. Surfactant replacement therapy has had a significant impact on the death rate from respiratory distress syndrome, yet the impact on bronchopulmonary dysplasia is minimal. Despite these findings, the overall incidence and severity of bronchopulmonary dysplasia are likely to decline over time as neonatal care continues to advance.

Original languageEnglish (US)
Pages (from-to)573-586
Number of pages14
JournalPediatric Clinics of North America
Issue number3
StatePublished - 1998

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health


Dive into the research topics of 'Bronchopulmonary dysplasia: Impact of surfactant replacement therapy'. Together they form a unique fingerprint.

Cite this